FDA product code · Clinical toxicology

Atomic Absorption Spectrophotometer, General Use

Name: FDA decisions, review times, recalls and adverse event reports for product code JXR
Creator: 510(k) Report

JXRClass I21 CFR 862.2850510(k) exempt29 decisions since 19760 recalls

FDA lists JXR as exempt from 510(k): a device of this type needs no clearance unless one of the limits in 21 CFR 862.9 applies, such as a new intended use or a different fundamental technology. 29 FDA decisions since 1976. No recall names this code.

Data to Oct 25, 2026 (FDA decisions) Oct 12, 2026 (recalls) Sep 30, 2026 (MAUDE) refreshed weekly, last Nov 3, 2026 Download the data (CSV)

FIG. A — Illustration, clinical toxicology panel

Twenty years of JXR at a glance: how often FDA decides these devices, how long 510(k) reviews take, how often they are recalled, and how many adverse event reports name the code.

FDA decisions per year · JXR

FDA has decided no JXR device since 2007.

Median 510(k) review, days · JXR

Too few JXR 510(k)s in any year since 2007 to give a median.

Recalls per year · JXR

No recall names JXR since 2007.

Adverse event reports per year · JXR

No MAUDE report names JXR since 2007.

View these four charts as a table

Year	Median 510(k) review, days	MAUDE reports
2007	—	0
2008	—	0
2009	—	0
2010	—	0
2011	—	0
2012	—	0
2013	—	0
2014	—	0
2015	—	0
2016	—	0
2017	—	0
2018	—	0
2019	—	0
2020	—	0
2021	—	0
2022	—	0
2023	—	0
2024	—	0
2025	—	0
2026	—	—

FIG. 1 — JXR by year, 2007–2026Sources: FDA decision databases, recall and enforcement reports, MAUDE · Data through Oct 25, 2026

Planning a device in JXR? A 510(k) Report ranks candidate predicates in this code by lineage, citations and recall history, with the review-time outlook.

See the 510(k) Report

Atomic Absorption Spectrophotometer, General Use

What has FDA decided in JXR lately?